NEURO-ONCOLOGY AND TARGETED THERAPIES FOR GLIOBLASTOMA
Gomal Journal of Life Sciences · 30.06.2024 · 2 (01) · 87-106
DOI: 10.66406/gjls0135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gomal Journal of Life Sciences, online erschienen am 30.06.2024. Verfasst von Wesam Taher Almagharbeh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Due to its nonresponsiveness to standard therapy, cellular diversity, and advanced growth rate, glioblastoma multiforme (GBM) is a great clinical problem. The research adopted a mixed-methods study that enrolled 120 GBM patients stratified into standard and targeted treatment groups to evaluate the effectiveness of the targeted medical techniques in the combination with neuro-oncology standards. The quantitative outcomes included MRI volumetrics, progression-free survival (PFS) and molecular biomarker dynamics measured using digital droplet PCR and next generation sequencing tools. Having achieved mean tumor volume reduction of 22% after three treatment courses, targeted therapies, namely, bevacizumab, EGFR inhibitors, and IDH1 modulators, showed a statistically significant improvement in PFS (p < 0.01). The responders had a stronger response towards treatment and a low rate of recurrence as seen with molecular responders; mostly on IDH 1 mutation and methylated MGMT promoter molecules. It was also found that the specific population has experienced a positive impact in terms of treatment satisfaction, emotional coping, and cognitive clarity during qualitative interviews with patients and caregivers. Thematic analysis confirmed that integrated care models proffered a disease pathway that was more dignified and manageable. On balance, this paper identifies that patient-centered and precision-driven care plays a decisive role in the treatment of GBM and provides a standardizable methodological scheme of further translation studies in neuro-oncology.
Zitieren
APA
Almagharbeh, W. T., & Ghaffar, A. (2024). NEURO-ONCOLOGY AND TARGETED THERAPIES FOR GLIOBLASTOMA. Gomal Journal of Life Sciences, 2(01), 87-106. https://doi.org/10.66406/gjls0135
Vancouver
Almagharbeh WT, Ghaffar A. NEURO-ONCOLOGY AND TARGETED THERAPIES FOR GLIOBLASTOMA. Gomal Journal of Life Sciences. 2024;2(01):87-106. doi:10.66406/gjls0135
BibTeX
@article{Almagharbeh2024,
author = {Almagharbeh, Wesam Taher and Ghaffar, Abdul},
title = {NEURO-ONCOLOGY AND TARGETED THERAPIES FOR GLIOBLASTOMA},
journal = {Gomal Journal of Life Sciences},
year = {2024},
volume = {2},
number = {01},
pages = {87--106},
doi = {10.66406/gjls0135}
}
EUVIMED